ORMP
ORAMED PHARMACEUTICALS INC. · Healthcare · Market cap $153.5M
Insiders sold $226K net in the last 90 days ·2 sellers, 0 buyers· 2 of 2 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 2, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.2M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Nov 14, 2026
Hexter Joshua
ORAMED PHARMACEUTICALS INC. (ORMP) has 36 SEC Form 4 filings (56 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Nov 14, 2026.
Inside the rolling window, 2 insiders at ORAMED PHARMACEUTICALS INC. reported no open-market purchases and 4 open-market sales totaling $1.2M. Insiders have net sold $1.2M over the trailing 6 months. The most recent open-market filing is a sale of 30,000 shares by COO & CBO Hexter Joshua, dated Oct 1, 2026, worth $135K.
- Industry:Biotechnology
- CEO:Nadav Kidron
- Employees:13
- HQ:New York City, NY, US
- IPO:2007-05-01
| Source | |||||||
|---|---|---|---|---|---|---|---|
Hexter JoshuaFirst in 3 months | COO & CBO | Sale | 30,000 | $135K | Oct 2 | -17.8% | SEC ↗ |
Gabay AvrahamFirst in 3 months | Chief Financial Officer | Sale | 20,000 | $90K | Oct 2 | -17.8% | SEC ↗ |
Hexter JoshuaFirst filing | COO & CBO | Sale | 137,000 | $611K | Jul 2 | -19.8% | SEC ↗ |
Gabay AvrahamFirst filing | Chief Financial Officer | Sale | 73,360 | $331K | Jul 2 | -19.8% | SEC ↗ |
Congress trading ORMP 4 all-time
- RRep. Brad KnottSale$15,001 - $50,0002025-01-10
- RRep. Andrew R. GarbarinoOther$1,001 - $15,0002022-01-14
- RRep. Andrew R. GarbarinoOther$1,001 - $15,0002021-10-01
- RRep. Andrew R. GarbarinoPurchase$1,001 - $15,0002021-04-23
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does ORMP have?
ORAMED PHARMACEUTICALS INC. (ORMP) has 36 SEC Form 4 filings (56 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Nov 14, 2026.
When was the most recent SEC Form 4 filing for ORMP?
The most recent Form 4 filing for ORMP on Tracefour is dated Nov 14, 2026.
What is the net insider flow at ORMP over the last 6 months?
Over the trailing 180 days, insiders at ORMP have net sold $1.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ORMP in the current window?
Inside the rolling window, insiders at ORMP bought $0 and sold $1.2M based on SEC Form 4 filings.
Can I get alerts for ORMP insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ORAMED PHARMACEUTICALS INC. (ORMP). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ORAMED PHARMACEUTICALS INC. is in the Healthcare sector.